Artiva biotherapeutics to participate in the cantor global healthcare conference 2025

San diego, aug. 25, 2025 (globe newswire) -- artiva biotherapeutics, inc. (nasdaq: artv), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate in a fireside chat at the cantor global healthcare conference 2025 on wednesday, september 3, 2025, at 9:45 a.m. edt.
ARTV Ratings Summary
ARTV Quant Ranking